Initiation of CFTR Modulator ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
299	Cystic fibrosis	2

299. Cystic fibrosis

---

Clinical trials : 1,696 /  Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04467957 (ClinicalTrials.gov)	October 1, 2020	19/6/2020	Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis	Non-contrast Lung Perfusion Mapping Applied for New Insights in Cystic Fibrosis	Cystic Fibrosis	Drug: Initiation of CFTR Modulator;Drug: Hyperpolarized Xenon 129	Children's Hospital Medical Center, Cincinnati	NULL	Not yet recruiting	6 Years	21 Years	All	26	Phase 4	NULL
2	NCT04259970 (ClinicalTrials.gov)	January 13, 2020	15/1/2020	Hyperpolarized Imaging for New Treatments	Hyperpolarized Imaging for New Treatments (HyPOINT) Study	Cystic Fibrosis	Drug: Initiation of CFTR Modulator	Children's Hospital Medical Center, Cincinnati	University of Virginia;University of Wisconsin, Madison;The Hospital for Sick Children	Recruiting	6 Years	18 Years	All	64	Phase 4	United States;Canada